- Home
- ULS vs WAT Comparison
ULS vs WAT Comparison
Compare ULS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULS
- WAT
- Stock Information
- Founded
- ULS 1894
- WAT 1958
- Country
- ULS United States
- WAT United States
- Employees
- ULS N/A
- WAT N/A
- Industry
- ULS
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ULS
- WAT Industrials
- Exchange
- ULS Nasdaq
- WAT Nasdaq
- Market Cap
- ULS 14.6B
- WAT 17.0B
- IPO Year
- ULS 2024
- WAT 1995
- Fundamental
- Price
- ULS $67.16
- WAT $291.56
- Analyst Decision
- ULS Buy
- WAT Hold
- Analyst Count
- ULS 8
- WAT 14
- Target Price
- ULS $69.25
- WAT $374.07
- AVG Volume (30 Days)
- ULS 1.0M
- WAT 1.0M
- Earning Date
- ULS 08-05-2025
- WAT 08-04-2025
- Dividend Yield
- ULS 0.77%
- WAT N/A
- EPS Growth
- ULS 21.42
- WAT 10.77
- EPS
- ULS 1.62
- WAT 11.09
- Revenue
- ULS $2,951,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- ULS $6.76
- WAT $6.27
- Revenue Next Year
- ULS $6.04
- WAT $6.49
- P/E Ratio
- ULS $41.50
- WAT $26.30
- Revenue Growth
- ULS 6.92
- WAT 5.89
- 52 Week Low
- ULS $46.79
- WAT $275.05
- 52 Week High
- ULS $74.15
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- ULS N/A
- WAT 44.31
- Support Level
- ULS N/A
- WAT $278.49
- Resistance Level
- ULS N/A
- WAT $296.89
- Average True Range (ATR)
- ULS 0.00
- WAT 7.48
- MACD
- ULS 0.00
- WAT 2.68
- Stochastic Oscillator
- ULS 0.00
- WAT 53.76
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.